We invite you to familiarize yourself with the exhibitors' developments in advance and receive your free ticket to the Pharmtech & Ingredients 2024 exhibition

The opening of the International Exhibition of Equipment, Raw Materials and Technologies for Pharmaceutical Production Pharmtech & Ingredients 2024 is getting closer. This year, a consistently high interest in the Russian market is observed from participants from China - more than 200 Chinese companies will demonstrate their products at the site. We invite you to familiarize yourself with the exhibitors' products.

Reducing waste in tablet production – making better use of your Canaan tablet press

Waste directly related to tablet pressing mainly involves the write-off of tablet residues and raw materials. These losses can be measured by the recovery ratio, which is the ratio between finished products and materials, and its value is always less than 100%. The parts of the losses mainly include:

// Tablet scrapping: poor quality tablets obtained due to various reasons (such as inaccurate tablet weight control, uneven materials, etc.) during the tablet pressing process.
// Material loss: Material waste caused by equipment clearances, powder leakage, etc. during tablet pressing process.

Ways to Reduce Waste

Improving the performance of tablet press

// Improve tablet weight control accuracy and reduce waste.
// Improve the rotation accuracy of the punch table and reduce the amount of powder leakage.

However, after reaching a certain level of accuracy, the cost of the equipment will increase significantly. Therefore, it is necessary to reduce waste by optimizing the design without significantly increasing costs.

Design optimization

// Reducing false rejections with a single tablet rejection system.
// Optimize the gap between the feeder and the punching table to reduce material loss.
// Using a fully closed lantern cover to solve the problem of tablet delamination caused by the dripping of the upper punch lubricating oil.

Canaan's T-Series tablet press effectively reduces waste with the following designs:

Single Tablet Waste Disposal System

// The sorting door of T series tablet press is designed inside the tablet pressing chamber, and the paddle is located close to the punch table, which shortens the opening and closing time, improves the rejection accuracy of used tablets and reduces the waste of good tablets.
// The feeder pre-rotation function ensures that the material in the feeder reaches the working state before the punch table starts, which reduces the amount of tablet waste during the start-up stage.

Built-in design

// The T series tablet press feeder adopts an insert design that can be adjusted to almost zero clearance, reducing material loss.
// Inserts of different specifications are suitable for tablets of different diameters, which improves the stability of tablet weight.

Fully enclosed Lantern case

// Solves the problem of tablet breakage caused by dripping of upper punch lubricating oil.
// Possibility to completely wrap the upper punch rod, with a larger capacity for oil and prevent it from falling.

We look forward to seeing you at the company stand C3087.

Linuo Leads Digital Transformation of China's Light Industry

On October 15, 2024, Shandong Linuo Technical Glass's pharmaceutical light glass bottle industrialization project was selected as a leading example of digital transformation of China Light Industry organizations.

Shandong Linuo Technical Glass Co., Ltd., founded in 1995, has been focusing on the research and development of advanced pharmaceutical glass packaging for 30 years. It is a high-tech enterprise whose main products are new glass materials, with more than 130 patented technologies. On November 11, 2021, the company was successfully listed on Shenzhen ChiNextboard with the stock code 301188. The main products of Linuo Technical Glass are: borosilicate glass ampoules, vials, cartridges, neutral borosilicate glass molded bottles, etc. It is one of the largest pharmaceutical packaging enterprises in China.

Linuo Technical Glass has always been committed to innovation in the field of pharmaceutical packaging and industrial upgrading. The high-end pharmaceutical packaging intelligent manufacturing project was launched with a total investment of 2 billion yuan. The project focuses on the production of neutral borosilicate glass molded bottles. The project adopts automated production lines and intelligent inspection systems, effectively reducing manual intervention and improving production efficiency and product quality. At the same time, through the construction of a digital workshop and intelligent logistics systems, it achieves real-time monitoring and flexible planning of the production process, and achieves shortened order lead times and accurate inventory management. The project also uses big data analysis technology to carry out deep extraction and analysis of production data, providing reliable support for product optimization and the adjustment of cost control and market strategies. Through this project, Linuo has been accredited as a “Provincial Intelligent Factory”.

Being selected as a leading example of digital transformation in China's light industry in 2024 is a recognition of Linuo Technical Glass's unremitting efforts in technological innovation. In the future, Linuo will continue to adhere to the concept of innovative development, explore new paths of intelligent manufacturing, and strive to promote the high-quality development of the global pharmaceutical packaging industry.

The company's products will be presented at stand A3021.

New type polymer pre-fillable syringes from Shandong Ujoin Medical

Compared with the glass pre-filled syringe, the polymer material used by the company has high biosafety, good drug compatibility, less protein adsorption, no heavy metal residue, good weather resistance, and can withstand high temperature, irradiation and other sterilization. With the technical performance of the product and the variety of drug administration forms (with needles, without needles and implantable drug administration forms), it can better meet the diverse needs of consumers in the health care field. This can realize large-scale production of multi-cavity injection molding with high efficiency, stable quality and no damage during the production process.

The company's specialists will be waiting for visitors at stand B2145.

Separation for chemical processes from WIGGENS Co., Ltd

Separation and purification are critical steps in pharmaceutical synthesis, and Wiggens offers a range of solutions for these critical processes, including distillation, crystallization and extraction. The company offers both standard packages and fully customized solutions to meet specific needs.

The rotary evaporator is used primarily for continuous distillation of large volumes of volatile solvents under reduced pressure, especially in chromatographic separations. It efficiently concentrates extracts and distills the resulting solutions, facilitating the separation and purification of reaction products. Wiggens offers models from benchtop to industrial scale, supporting volumes up to 100 liters.

The thin film evaporator is a high-performance device designed for precise separation and concentration of volatile components. Molecular distillation, operating at pressures down to 0.001 mbar, allows the evaporation of heat-sensitive materials with minimal residence time. The product is evenly distributed throughout the heated cylinder by a film scraping system, ensuring efficient evaporation.

With the use of an advanced control system, all processes can be fully automated, which increases operational efficiency and reliability.

Visit the company stand C2057.

Improving the sustainability of medicines - an innovative project from XINFUDA

Pharmaceutical companies know that the stability of the external environment for drugs is the key to ensuring the effectiveness of drugs. During the storage and transportation of drugs, any small change can affect the quality of the drug. Humidity is one of the serious reasons, and it is important to prevent it. Therefore, the company began to pay attention to the packaging with the effect of moisture barrier, ensuring the stability of the storage environment for the drug.

Double protection from the inside

The packaging is hermetically sealed, has an optimal level of water absorption, insulation, and internal moisture resistance (inside the can).

Innovative projects of moisture-resistant packaging

Shijiazhuang Xinfuda Medical Packaging Co.,Ltd launched a series of high-quality moisture-proof products with the size from 25ml to 200ml, suitable for tablets and capsules and other medicines. It was created by adopting high-quality high-molecular materials, innovative molding design, moisture insulation technology.

The company produces an integral multifunctional lid with a desiccant, automatic filling produces an accurate dose, the characteristics strictly comply with industry standards, so that the effect of moisture insulation is ensured, as well as safety when used at home.

Ongoing challenges and directions of industry development

At present, there are several innovative projects in the industry to create moisture-proof packaging, but there is still a need to continuously improve the technology level to meet the rapidly changing market demand. With continuous technological innovation and material research and development, pharmaceutical packaging manufacturers can continuously optimize packaging solutions to meet the high quality requirements of the industry. Only in this way can the pharmaceutical industry achieve sustainable development while ensuring the quality of drugs.

Shijiazhuang Xinfuda Medical Packaging Co., Ltd is committed to providing comprehensive functional packaging solutions. Product series: effervescent tablet packaging, COP bottles, syringe with adapter, eye drop bottles, liquid medicine packaging bottle, child-proof cap jars, customized services. The company has three production bases: Shijiazhuang City, Luoyang, Cangzhou. R&D center is Suzhou City.

The company's products will be presented at stand A2041.

Zemley, pharmaceutical services and solutions - from supplier to partner

Zemley offers integrated pharmaceutical packaging solutions and services that simplify every stage of drug development. The goal is to accelerate the time to market of new drugs while minimizing risk, helping customers achieve their goals. These services and solutions support you from R&D to launch. The company provides packaging support, combination product expertise, regulatory and technical assistance, analytical testing, state-of-the-art laboratory capabilities and ongoing consulting. Zemley aims to be a trusted partner for pharmaceutical companies in the packaging and delivery of drugs.

Visit the company's stand C5081.

Zhejiang Peptites Biotech Co., Ltd. (ZPC) is pleased to announce its participation in Pharmtech & Ingredients

Founded in 2015, ZPC is engaged in research and development (R&D) and production technologies for peptide products, including peptide-active pharmaceutical ingredients (APIs), cosmetic and food peptides. To date, 78 patents have been obtained for inventions. The company is one of the leaders in the field of peptide API and cosmetic peptide production.

ZPC has successfully launched more than 40 APIs, including leuprolide acetate, liraglutide, semaglutide, tirzepatide, lanreotide and linaclotide, by using advanced solid-phase peptide synthesis technology. Among them, leuprolide acetate has been registered by NMPA, CEP and FDA, liraglutide, semaglutide and tirzepatide have obtained DMF in the US.

ZPC expands its production scale and improves its production efficiency to meet the growing demand for high-quality peptide APIs in both domestic and overseas markets. The estimated annual production capacity of peptide APIs reaches 1.5 tons and 5.4 tons of cosmetic peptides, respectively. To improve the purity and potency of the product, ZPC adopts a series of independent core technologies, including resin functional modification technology, special amino acid fragment synthesis technology and long segment peptide synthesis technology. In addition, strict quality control is implemented to ensure the product purity is over 99%. With advanced peptide synthesis, modification, production and development technologies, ZPC offers Clinical Research Organization (CRO), Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) services, which provide one-stop solutions to facilitate the launch of new drugs for customers.

ZPC looks forward to discussing industry issues and trends, and sharing more detailed product and service information at booth B3098.

We are waiting for you and your colleagues at the Pharmtech & Ingredients 2024 exhibition on November 19-22, Crocus Expo IEC, Pavilion 2. Hurry up to get a free ticket using the promo code news